Author:
Hruska J F,Bernstein J M,Douglas R G,Hall C B
Abstract
Ribavirin was demonstrated to have an antiviral effect on respiratory syncytial virus in vitro. A 50% reduction in plaque number was observed at concentrations of 3 or 10 micrograms of ribavirin per ml. This effect was observed when the drug was added as late as 12 h postinfection. At concentrations of greater than 10 micrograms of ribavirin per ml, the size of the syncytial plaque also noticeably decreased. Ribavirin similarly decreased the number of infectious units released into the culture supernatant. The antiviral effect was observed to be inversely related to the size of the viral inoculum, although all concentrations above 3.2 micrograms of ribavirin per ml visibly lessened the cytopathic effect regardless of the inoculum. Cloning of respiratory synctial virus in inhibitory concentrations of ribavirin failed to show increased resistance to the drug.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference20 articles.
1. Chanock R. M. H. W. Kim C. Brandt and R. H. Parrott. 1976. Respiratory syncytial virus p. 365-382. In A. L. Evans (ed.) Viral infection of humans. Plenum Publishing Corp. New York.
2. Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A;Cohen A.;J. Infect. Dis.,1976
3. Efficacy of ribavirin against influenza virus in tissue culture and in mice;Durr F. E.;Ann. N. Y. Acad. Sci.,1975
4. Efficacy of 1-,8-D-ribofuranosy1-1,2,4-triazole-3-carboxamide against influenza virus infections in mice;Durr F. E.;Antimicrob. Agents Chemother.,1975
5. In vitro effect of 1-,6-D-ribofuranosy1-1,2,4-triazole-3-carboxamide (Virazole, ICN 1229) on deoxyribonuleic acid and ribonucleic acid viruses;Huffman J. H.;Antimicrob. Agents Chemother.,1973
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献